期刊文献+

FXR激动剂GW4064对裸鼠肝癌细胞移植瘤增殖及血管生成的影响 被引量:3

Effect of FXR Agonist GW4064 on the Proliferation and Angiogenesis of HCC Cells in Nude Mice
原文传递
导出
摘要 目的:探讨研究法尼酯x受体(FXR)激动剂GW4064对裸鼠肝癌细胞移植瘤增殖及血管生成的影响。方法:选取人肝癌细胞系Hep G2进行体外培养,将细胞悬液接种于BALB/c裸鼠皮下。裸鼠成瘤后,随机分为两组,分别腹腔注射DMSO和GW4064。一周后,处死动物取肿瘤组织,通过免疫组织化学法检测肿瘤组织中Ki-67和CD31的表达,同时计数肿瘤组织中的微血管密度(CD31-MVD);Western blot法检测其FXR和白介素-8(IL-8)的蛋白表达。结果:与对照组相比,FXR激动剂GW4064处理组的肿瘤组织中FXR的蛋白表达量明显增高,微血管密度CD31-MVD值显著降低,同时Ki-67、IL-8及CD31的表达水平均显著降低。结论:FXR激动剂GW4064能显著增加FXR的表达,抑制裸鼠肝癌细胞移植瘤的增殖及新生血管的形成。 Objective:To investigate the effect of FXR agonist GW4064 on the proliferation and angiogenesis of hepatocellular carcinoma (HCC)cells in BALB/c nude mice.Methods:Human hepatocellular carcinoma cell line HepG2 were cultured in vitro,then implanted subcutaneously in nude mice.When the subcutaneous xenograft was formed,the nude mice were randomly divided into a control group and an experimental group,which were injected with DMSO and GW4064 respectively.After one week,the tumor was separated,the expression of Ki67 and CD31 were detected by immunohistochemical(IHC) method,the microvessel density (CD31-MVD) of tumors were calculated,and the expression of FXR and IL-8 were detected by Western blot assays.Results:Compared with control group,the expression of FXR increased significantly,the microvessel density CD31-MVD value decreased significantly,while the expression level ofKi-67,IL-8 and CD3 1were significantly inhibited in GW4064 group.Conclusion:FXR agonist GW4064 may stimulate the expression of FXR thereby inhibiting the cell proliferation and tumor angiogenesis of hepatocellular carcinoma cell xenografts in nude mice.
出处 《现代生物医学进展》 CAS 2015年第4期607-609,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30901220)
关键词 法尼酯X受体 GW4064 白介素-8 增殖 血管生成 肝癌 FXR Proliferation Angiogenesis Hepatocellular carcinoma
  • 相关文献

参考文献2

二级参考文献15

  • 1彭屹峰,陈绍亮.衍射增强技术对肝脏诊断的意义[J].中华肝脏病杂志,2006,14(10):782-783. 被引量:3
  • 2D Dimitroulopoulos,D Xinopoulos,K Tsamakidis,A Zisimopoulos,E Andriotis,D Panagiotakos,A Fotopoulou,C Chrysohoou,A Bazinis,D Daskalopoulou,E Paraskevas.Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: Randomized placebo-controlled trial[J].World Journal of Gastroenterology,2007,13(23):3164-3170. 被引量:18
  • 3Ramesh K. Ramanathan,Chandra P. Belani,Deepti A. Singh,Michael Tanaka,Heinz-Josef Lenz,Yun Yen,Hedy L. Kindler,Syma Iqbal,Jeff Longmate,Philip C. Mack,Georg Lurje,Regina Gandour-Edwards,Janet Dancey,David R. Gandara.A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer[J].Cancer Chemotherapy and Pharmacology.2009(4) 被引量:2
  • 4Sandrine Faivre,Eric Raymond,Eveline Boucher,Jean Douillard,Ho Y Lim,Jun S Kim,Magaly Zappa,Silvana Lanzalone,Xun Lin,Samuel DePrimo,Charles Harmon,Ana Ruiz-Garcia,Maria J Lechuga,Ann Lii Cheng.Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study[J].Lancet Oncology.2009(8) 被引量:1
  • 5Augusto Villanueva,Derek Y. Chiang,Pippa Newell,Judit Peix,Swan Thung,Clara Alsinet,Victoria Tovar,Sasan Roayaie,Beatriz Minguez,Manel Sole,Carlo Battiston,Stijn van Laarhoven,Maria I. Fiel,Analisa Di Feo,Yujin Hoshida,Steven Yea,Sara Toffanin,Alex Ramos,John A. Martignetti,Vincenzo Mazzaferro,Jordi Bruix,Samuel Waxman,Myron Schwartz,Matthew Meyerson,Scott L. Friedman,Josep M. Llovet.Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma[J].Gastroenterology.2008(6) 被引量:1
  • 6Hashem B. El-Serag,Jorge A. Marrero,Lenhard Rudolph,K. Rajender Reddy.Diagnosis and Treatment of Hepatocellular Carcinoma[J].Gastroenterology.2008(6) 被引量:4
  • 7Josep M. Llovet,Jordi Bruix.Novel advancements in the management of hepatocellular carcinoma in 2008[J].Journal of Hepatology.2008 被引量:8
  • 8Andrew X.Zhu,KeithStuart,Lawrence S.Blaszkowsky,AlonaMuzikansky,Donald P.Reitberg,Jeffrey W.Clark,Peter C.Enzinger,PankajBhargava,Jeffrey A.Meyerhardt,KerryHorgan,Charles S.Fuchs,David P.Ryan.Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma[J].Cancer.2007(3) 被引量:1
  • 9Pierre-A Clavien.Interferon: The Magic Bullet to Prevent Hepatocellular Carcinoma Recurrence After Resection?[J].Annals of Surgery.2007(6) 被引量:1
  • 10Josep M. Llovet,Yingbei Chen,Elisa Wurmbach,Sasan Roayaie,M. Isabel Fiel,Myron Schwartz,Swan N. Thung,Gregory Khitrov,Weijia Zhang,Augusto Villanueva,Carlo Battiston,Vincenzo Mazzaferro,Jordi Bruix,Samuel Waxman,Scott L. Friedman.A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis[J].Gastroenterology.2006(6) 被引量:1

共引文献18

同被引文献32

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部